| Product Code: ETC7552306 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India RNA Targeting Small Molecule Drug Discovery Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 India RNA Targeting Small Molecule Drug Discovery Market - Industry Life Cycle |
3.4 India RNA Targeting Small Molecule Drug Discovery Market - Porter's Five Forces |
3.5 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 India RNA Targeting Small Molecule Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases that can be targeted through RNA-based therapies |
4.2.2 Advancements in technology and research in the field of RNA targeting small molecule drug discovery |
4.2.3 Growing investments in healthcare and pharmaceutical sectors in India |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in India |
4.3.2 High costs associated with research and development of RNA targeting small molecule drugs |
4.3.3 Limited availability of skilled professionals in the field of RNA therapeutics in India |
5 India RNA Targeting Small Molecule Drug Discovery Market Trends |
6 India RNA Targeting Small Molecule Drug Discovery Market, By Types |
6.1 India RNA Targeting Small Molecule Drug Discovery Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.4 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.5 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Metabolic Diseases, 2021- 2031F |
6.1.6 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.1.7 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India RNA Targeting Small Molecule Drug Discovery Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical Companies, 2021- 2031F |
6.2.3 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.2.4 India RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
7 India RNA Targeting Small Molecule Drug Discovery Market Import-Export Trade Statistics |
7.1 India RNA Targeting Small Molecule Drug Discovery Market Export to Major Countries |
7.2 India RNA Targeting Small Molecule Drug Discovery Market Imports from Major Countries |
8 India RNA Targeting Small Molecule Drug Discovery Market Key Performance Indicators |
8.1 Number of research publications related to RNA targeting small molecule drug discovery in India |
8.2 Percentage increase in funding for RNA targeting small molecule drug research projects in India |
8.3 Number of collaborations between Indian pharmaceutical companies and research institutions for RNA therapeutics |
9 India RNA Targeting Small Molecule Drug Discovery Market - Opportunity Assessment |
9.1 India RNA Targeting Small Molecule Drug Discovery Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 India RNA Targeting Small Molecule Drug Discovery Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 India RNA Targeting Small Molecule Drug Discovery Market - Competitive Landscape |
10.1 India RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 India RNA Targeting Small Molecule Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here